How to improve the success rate in Kyrgyz Tulip International Reproductive Center? Six key links are more important than blindly entering the week.

What is "improving the success rate"? Don't just stare at a number yet.

When many people consult "How to improve the success rate in Kyrgyz Tulip International Reproductive Center", it is easy to understand the problem as: if you change a hospital and change a technology, the results will be obviously different. This understanding is incomplete.

From a medical point of view, the results of IVF are influenced by many factors, including female age, ovarian reserve, sperm quality, embryo development, endometrial status, previous abortion history, basic diseases, laboratory conditions and transplantation strategies. CDC also suggested that the outcome of assisted reproduction would change with age, infertility diagnosis, previous pregnancy history and ART program used, and the average data could not be directly equivalent to individual results.

Therefore, the so-called "improving the success rate", more accurately, is to reduce controllable risks, reduce invalid attempts and improve the matching degree of each step, rather than promising a fixed result.

Expert tip: IVF is not a single technology to determine the result, but a systematic project of "physical condition+medical plan+laboratory management+transplant opportunity+follow-up management". Any statement that directly promises the result does not conform to strict medical expression.

Technical links: Embryo quality, laboratory and screening strategy are the core variables.

In order to improve the stability of assisted reproduction in Kyrgyzstan Tulip International Reproductive Center, the technical level usually pays attention to three directions.

The first is whether the emission promotion plan is individualized. Different groups of people cannot apply the same scheme. People with low ovarian reserve, older age, polycystic ovary tendency and poor response to ovulation promotion in the past have completely different program priorities. The appropriate ovulation promotion is not to pursue the more eggs taken, the better, but to obtain usable eggs within a safe range and minimize the risks such as overstimulation.

Secondly, embryo culture and selection. ESHRE data show that ICSI accounts for a relatively high proportion in assisted reproductive therapy in the world, accounting for about 73% of the total treatment; At the same time, vitrification technology has improved the clinical application effect of frozen embryos and oocytes, and the results of frozen embryo transfer have also improved in recent years. This shows that laboratory operation, embryo culture system and frozen resuscitation management will all affect the follow-up transplant arrangement.

The third is the rational use of genetic screening. For the elderly, people with repeated planting failure, repeated abortion and high risk of chromosome abnormality, PGT-A and other embryonic chromosome screening may have reference value. In 2024, the Committee of ASRM mentioned that in the data of SART 2019, PGT-A was associated with higher implantation rate and lower abortion rate in some age groups, especially in older groups.

But that doesn't mean everyone has to be screened. PGT-A can not change the quality of the embryo itself, nor can it guarantee pregnancy or live birth. Its value lies in helping doctors choose embryos more effectively and reducing the risk of partial invalid transplantation or abortion.

Expert tip: Embryo screening is suitable for some people with medical indications, which cannot be simply understood as "it will be easier to succeed after screening". Whether screening is necessary should be decided according to age, number of embryos, past medical history and doctor's evaluation.

Who needs success rate management in advance?

If you are young, the ovarian function is acceptable, the male semen parameters are stable, and the uterine environment is good, the test tube scheme is relatively straightforward. However, the following groups of people need to be carefully managed before entering the cycle.

First, people who are older or have lower AMH. Age will affect the quality of eggs and the normal rate of embryo chromosomes, which is a difficult factor to reverse in clinic. For this kind of people, the key is not to delay waiting, but to complete the evaluation as soon as possible and formulate the egg retrieval rhythm and embryo accumulation strategy.

The second is the people who have failed to transplant repeatedly. Not only repeated transplantation, but also back to check whether there are abnormalities in embryo quality, intima thickness, intrauterine environment, immunity and coagulation-related factors. Blindly repeating the cycle may increase time and economic costs.

Third, people with recurrent spontaneous abortion. It is necessary to focus on chromosome, endocrine, uterine structure, immunity, blood coagulation and other factors. If necessary, embryo screening and pre-pregnancy risk control can be discussed.

The fourth is the group with abnormal sperm quality. Sperm concentration, motility, morphology and DNA fragmentation rate will all affect fertilization, embryo development and subsequent pregnancy stability. The man can't finish the evaluation just by doing a general semen test.

Fifth, people with endometrial problems. For example, thin endometrium, intrauterine adhesions, polyps, fibroids, chronic endometritis, etc., may affect embryo implantation. To improve the success rate, we should not only look at the embryo, but also look at the "soil".

Process management: From inspection to transplantation, errors should be reduced at every step.

In order to improve the success rate of test tubes in Kyrgyzstan Tulip International Reproductive Center, it is suggested to focus on the following nodes in the process.

The first node is pre-inspection. Women usually need to evaluate AMH, basal follicles, sex hormones, thyroid gland, prolactin, blood sugar, infection screening, uterine cavity, etc. Men need semen analysis, and if necessary, increase the rate of sperm DNA fragments. The more complete the inspection, the less likely the scheme will go astray.

The second node is emission monitoring. During ovulation promotion, the medication should be adjusted according to follicular development and hormone changes, rather than a fixed dose for the whole cycle. Inadequate monitoring may lead to unsynchronized follicular maturation, which may also increase the safety risk.

The third node is egg retrieval and fertilization mode selection. If there are sperm quality problems and low previous fertilization rate, doctors may consider ICSI and other methods. Which way to choose should be based on medical conditions, rather than simply pursuing technology that sounds more advanced.

The fourth node is the opportunity of embryo culture and transplantation. Some people are suitable for fresh embryo transfer, others are more suitable for freezing embryos first, and then transplanting them after the intima, hormones and physical state are more stable. Frozen embryos are not the second best, and are often used in clinic to leave room for physical recovery and endometrial preparation.

The fifth node is post-transplant management. It is not recommended to stay in bed for a long time after transplantation, and it is not recommended to repeatedly test too nervously. We should use corpus luteum support according to the doctor's advice, check pregnancy at the prescribed time, and pay attention to abnormal signals such as abdominal pain, bleeding and abdominal distension.

Expert tip: to improve the success rate, it is not to do all the projects once, but to accurately match "the inspection to be done, the technology to be used and the risks to be avoided" to the personal situation. Excessive medical treatment and insufficient examination will affect the overall efficiency.

Frequently asked questions: What customers really care about

Q: Does the success rate of making test tubes at the Tulip International Reproductive Center in Kyrgyzstan mainly depend on the hospital?

No. Hospital and laboratory conditions are important, but personal basic conditions are equally critical. In particular, age, ovarian reserve, embryo quality, endometrial status and past medical history will directly affect the results. Medically, it is more recommended to look at the "expected results after individual evaluation" rather than just the propaganda figures.

Q: Is the success rate of third-generation test tubes necessarily higher than that of ordinary test tubes?

Can't understand it like this. The core value of the third generation test tube is genetic testing of embryos, which is suitable for some people with chromosome risk, repeated abortion, repeated failure or the elderly. For young people with few embryos and no clear indications, whether screening is needed should be carefully evaluated.

Q: How many embryos can be transplanted more successfully?

No, the more transplants, the better. Multiple embryo transfer may increase the risk of multiple pregnancy, which is related to the risks of premature delivery, low birth weight and pregnancy complications. ESHRE has also issued a guideline on the number of embryo transfers, emphasizing the need to decide the number of embryo transfers based on safety and individual conditions.

Q: Does lifestyle really affect the test tube results?

It will have an impact, but it is not a deification. Regular work and rest, weight control, quitting smoking and drinking, improving sleep, managing blood sugar and thyroid function are of practical significance to the environment of eggs, sperm and endometrium. WHO also defines infertility as a reproductive system disease, and points out that about one-sixth of the people of childbearing age in the world will experience infertility in their lifetime, which shows that it is very important to standardize diagnosis and treatment and health management.

Summary: the essence of improving the success rate is to improve the "matching degree"

How to improve the success rate in Kyrgyz Tulip International Reproductive Center? The core is not to find a simple answer, but to do six things well: complete examination, individualized promotion of ovulation, emphasis on male factors, scientific selection of embryos, optimization of endometrial environment, and standardized post-transplant management.

For people who are going to Kyrgyzstan to do test tubes, it is suggested to make clear which category they belong to: age factor, ovarian reserve factor, male factor, embryo factor, endometrial factor, or previous failure factor. Only by classifying the problems clearly can the follow-up plan be more targeted.